Sleep apnea is prevalent in patients with HF, adding a high-risk comorbidity that can persist even after heart transplant, say the authors of a new study. The findings highlight the important role ...
HIGHLANDS RANCH, Colo., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative ...
OSA, a sleep disorder where breathing repeatedly stops during sleep due to blocked upper airways, affects nearly one billion people globally 1, yet approximately 80% of cases remain undiagnosed and ...
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...